Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease
© 2020, IPNA. Background: Vitamin C deficiency is common in chronic kidney disease (CKD) due to losses through dialysis and dietary intake below requirement. We investigated prevalence of vitamin C deficiency and impact of vitamin C treatment in deficient/insufficient patients. Methods: A prospectiv...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088098349&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70935 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-70935 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-709352020-10-14T08:45:06Z Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease Nattaphorn Hongsawong Notethasoung Chawprang Kulnipa Kittisakmontri Parach Vittayananan Konggrapun Srisuwan Wattana Chartapisak Medicine © 2020, IPNA. Background: Vitamin C deficiency is common in chronic kidney disease (CKD) due to losses through dialysis and dietary intake below requirement. We investigated prevalence of vitamin C deficiency and impact of vitamin C treatment in deficient/insufficient patients. Methods: A prospective cohort study in patients aged 1–18 years with CKD stages 4 and 5D collected demographic data including underlying disease, treatment, and anthropometric assessment. Vitamin C intake was assessed using 24-h dietary recall. Hemoglobin, iron status, serum vitamin C, and serum oxalate were measured at baseline and after treatment. Vitamin C (250 mg/day) was given orally for 3 months to deficient/insufficient patients. Results: Nineteen patients (mean age 12.00 ± 4.1 years) showed prevalence of 10.6% vitamin C insufficiency and 78.9% deficiency. There were no associations between vitamin C level and daily vitamin C intake (p = 0.64) or nutritional status (p = 0.87). Median serum vitamin C was 1.51 (0.30–1.90) mg/L. In 16 patients receiving treatment, median serum vitamin C increased from 1.30 (0.23–1.78) to 3.22 (1.77–5.96) mg/L (p = 0.008) without increasing serum oxalate (79.92 (56.6–106.84) vs. 80.47 (56.88–102.95) μmol/L, p = 0.82). However, 62.5% failed to achieve normal vitamin C levels. Ordinal regression analysis revealed patients with non-oligoanuric CKD were less likely to achieve normal vitamin C levels (β = − 3.41, p = 0.03). Conclusion: We describe high prevalence of vitamin C insufficiency/deficiency among pediatric CKD patients. Vitamin C levels could not be solely predicted by nutritional status or daily intake. The treatment regimen raised serum vitamin C without increasing serum oxalate; however, it was largely insufficient to normalize levels, particularly in non-oligoanuric CKD. [Figure not available: see fulltext.]. 2020-10-14T08:45:06Z 2020-10-14T08:45:06Z 2020-01-01 Journal 1432198X 0931041X 2-s2.0-85088098349 10.1007/s00467-020-04662-9 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088098349&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70935 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Chiang Mai University Library |
collection |
CMU Intellectual Repository |
topic |
Medicine |
spellingShingle |
Medicine Nattaphorn Hongsawong Notethasoung Chawprang Kulnipa Kittisakmontri Parach Vittayananan Konggrapun Srisuwan Wattana Chartapisak Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
description |
© 2020, IPNA. Background: Vitamin C deficiency is common in chronic kidney disease (CKD) due to losses through dialysis and dietary intake below requirement. We investigated prevalence of vitamin C deficiency and impact of vitamin C treatment in deficient/insufficient patients. Methods: A prospective cohort study in patients aged 1–18 years with CKD stages 4 and 5D collected demographic data including underlying disease, treatment, and anthropometric assessment. Vitamin C intake was assessed using 24-h dietary recall. Hemoglobin, iron status, serum vitamin C, and serum oxalate were measured at baseline and after treatment. Vitamin C (250 mg/day) was given orally for 3 months to deficient/insufficient patients. Results: Nineteen patients (mean age 12.00 ± 4.1 years) showed prevalence of 10.6% vitamin C insufficiency and 78.9% deficiency. There were no associations between vitamin C level and daily vitamin C intake (p = 0.64) or nutritional status (p = 0.87). Median serum vitamin C was 1.51 (0.30–1.90) mg/L. In 16 patients receiving treatment, median serum vitamin C increased from 1.30 (0.23–1.78) to 3.22 (1.77–5.96) mg/L (p = 0.008) without increasing serum oxalate (79.92 (56.6–106.84) vs. 80.47 (56.88–102.95) μmol/L, p = 0.82). However, 62.5% failed to achieve normal vitamin C levels. Ordinal regression analysis revealed patients with non-oligoanuric CKD were less likely to achieve normal vitamin C levels (β = − 3.41, p = 0.03). Conclusion: We describe high prevalence of vitamin C insufficiency/deficiency among pediatric CKD patients. Vitamin C levels could not be solely predicted by nutritional status or daily intake. The treatment regimen raised serum vitamin C without increasing serum oxalate; however, it was largely insufficient to normalize levels, particularly in non-oligoanuric CKD. [Figure not available: see fulltext.]. |
format |
Journal |
author |
Nattaphorn Hongsawong Notethasoung Chawprang Kulnipa Kittisakmontri Parach Vittayananan Konggrapun Srisuwan Wattana Chartapisak |
author_facet |
Nattaphorn Hongsawong Notethasoung Chawprang Kulnipa Kittisakmontri Parach Vittayananan Konggrapun Srisuwan Wattana Chartapisak |
author_sort |
Nattaphorn Hongsawong |
title |
Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
title_short |
Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
title_full |
Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
title_fullStr |
Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
title_full_unstemmed |
Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease |
title_sort |
vitamin c deficiency and impact of vitamin c administration among pediatric patients with advanced chronic kidney disease |
publishDate |
2020 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088098349&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70935 |
_version_ |
1681752993300480000 |